Definium Therapeutics Executives Sell Shares on March 25, 2026.

Definium Therapeutics, Inc. has recently disclosed that Director and Chief Executive Officer Robert Barrow has sold 24,431 shares at a price of $18.47 per share on March 25, 2026. Additionally, Chief Medical Officer Daniel Karlin has sold 8,018 shares at the same price on the same day, and Chief Legal Officer Mark Sullivan has sold 10,702 shares at $18.47 per share on March 25, 2026.